Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hepatitis
ADR ID BADD_A02019
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.07      Hepatocellular damage and hepatitis NEC
09.01.07.004      Hepatitis
Description INFLAMMATION of the LIVER. [MeSH]
MedDRA Code 10019717
MeSH ID D006505
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hepatitis | Hepatitis in other infectious diseases classified elsewhere | Hepatitis nonicteric | Hepatitis nonspecific | Hepatitis NOS | Hepatitis reactive non-specific | Hepatitis symptom | Hepatitis, unspecified | Nonspecific hepatitis | Hepatitis aggravated | Hepatitis non-icteric | Syncytial giant cell hepatitis | Hepatitis flare | Liver inflammation | Icteric hepatitis | Hepatitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02412Octreotide0.000186%
BADD_D02436Atorvastatin--
BADD_D02464Fingolimod0.003544%
BADD_D02470Nintedanib0.000940%
BADD_D02473Sodium chloride--
BADD_D02480Alectinib0.000504%
BADD_D02483Ribociclib0.000504%
BADD_D02487Baricitinib0.000362%
BADD_D02498Abemaciclib--
BADD_D02506Erdafitinib0.000168%
BADD_D02517Enasidenib0.000112%
BADD_D02540Capmatinib0.000224%
BADD_D02568Lutetium oxodotreotide lu-177-
BADD_D02577Oseltamivir acid0.000991%
BADD_D02588Remdesivir0.001609%
BADD_D02596Sotorasib0.000280%
BADD_D02630Oxyphenbutazone--
BADD_D02631Phenylbutazone--
The 21th Page    First    Pre   21    Total 21 Pages
ADReCS-Target
ADR Term Drug Name Target